Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

650
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
650
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

456
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
456
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K
Relative Risk01:12

Relative Risk

2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

290
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending the Median Odds Ratio (MOR), the Interval Odds Ratio (IOR), and the Proportion of Opposed Odds Ratios (POOR) for Use With 3-Level Multilevel Logistic Regression Models.

Statistics in medicine·2026
Same author

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials.

Statistics in medicine·2026
Same author

The Impact of Two Data-Generating Processes for Competing Risk Data on the Discrimination and Calibration of Two Types of Competing Risk Regression Models.

Statistics in medicine·2026
Same author

A nonparametric dependent competing risk method for net survival analysis.

The international journal of biostatistics·2026
Same author

Patterns and Outcomes of Completeness of Revascularization in Patients With Diabetes and Non-ST-Segment-Elevation Myocardial Infarction in Ontario, Canada.

Circulation. Population health and outcomes·2026
Same author

Prediction of transition probabilities in multi-state models with nested case-control data.

Biometrics·2025
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Practical recommendations for reporting Fine-Gray model analyses for competing risk data.

Peter C Austin1,2,3, Jason P Fine4,5

  • 1Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.

Statistics in Medicine
|September 16, 2017
PubMed
Summary
This summary is machine-generated.

Competing risks in survival analysis require careful interpretation. This review highlights common misinterpretations of the Fine-Gray model

Keywords:
competing riskscumulative incidence functionsubdistribution hazard modelsurvival analysis

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

951

Related Experiment Videos

Last Updated: Feb 22, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

951

Area of Science:

  • Biostatistics
  • Medical Research Methodology
  • Epidemiology

Background:

  • Medical research frequently encounters competing risks, where one event prevents another.
  • Survival analysis models are crucial for understanding event occurrences over time.
  • Competing risk regression models address covariate effects on event rates and probabilities.

Purpose of the Study:

  • To review the application and interpretation of the Fine-Gray subdistribution hazard model in medical literature from 2015.
  • To identify and address prevalent unclear or incorrect interpretations of regression coefficients in this model.
  • To provide clear guidelines for reporting and interpreting Fine-Gray model coefficients.

Main Methods:

  • Literature review of medical articles published in 2015 utilizing the Fine-Gray model.
  • Analysis of how regression coefficients from the Fine-Gray model were reported and interpreted.
  • Identification of common errors in interpreting covariate effects on subdistribution hazards.

Main Results:

  • A significant number of studies exhibited unclear or incorrect interpretations of Fine-Gray model regression coefficients.
  • Inconsistent interpretations can lead to confusion and misrepresentation of covariate-outcome associations.
  • Misinterpretation affects the understanding of the magnitude of associations between exposures and outcomes.

Conclusions:

  • Accurate interpretation of Fine-Gray model coefficients is essential for reliable medical research.
  • Clear reporting and interpretation guidelines are needed to prevent confusion and ensure correct understanding of competing risk analyses.
  • This article aims to clarify correct interpretation methods for regression coefficients in competing risk survival analysis.